# Cryoablation, Radiofrequency Ablation, or Microwave Ablation in Treating Patients With Metastatic Sarcoma Stable on Chemotherapy

> **NCT01986829** · PHASE2 · TERMINATED · sponsor: **Washington University School of Medicine** · enrollment: 9 (actual)

## Conditions studied

- Osteosarcoma
- Sarcoma

## Interventions

- **DEVICE:** Microwave ablation
- **DEVICE:** Cryoablation
- **DEVICE:** Radiofrequency ablation
- **OTHER:** BPI-Short form
- **OTHER:** FACT-G7

## Key facts

- **NCT ID:** NCT01986829
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-02-03
- **Primary completion:** 2017-08-08
- **Final completion:** 2017-08-08
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** Slow accrual
- **Last updated:** 2018-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01986829

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01986829, "Cryoablation, Radiofrequency Ablation, or Microwave Ablation in Treating Patients With Metastatic Sarcoma Stable on Chemotherapy". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01986829. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*